Expression of Epstein–Barr virus in Hodgkin lymphoma in a population of United Arab Emirates nationals

References

• Marafioti T, Hummel M, Foss H D, Laumen H, Korbjuhn P, Anagnostopoulos I, et al. Hodgkin and Reed–Sternberg cells represent an expansion of a single clone originating from a germinal center B-cell with functional immunoglobulin gene rearrangements but defective immunoglobulin transcription. Blood 2000; 95: 1443–1450
   PubMed Web of Science ®Google Scholar
• Higgins R A, Blankenship J E, Kinney M C. Application of immunohistochemistry in the diagnosis of non-Hodgkin and Hodgkin lymphoma. Arch Pathol Lab Med 2008; 132: 441–461
   PubMed Web of Science ®Google Scholar
• Castella A, Joshi S, Raaschou T, Mason N. Pattern of malignant lymphoma in the United Arab Emirates–a histopathologic and immunologic study in 208 native patients. Acta Oncol 2001; 40: 660–664
   PubMed Web of Science ®Google Scholar
• Bamanikar S, Thunold S, Devi K RL, Bamanikar A. The pattern of malignant lymphoma in Oman. J Tropical Med Hyg 1995; 98: 351–354
   PubMedGoogle Scholar
• Glaser S L, Lin R J, Stewart S L, Ambinder R F, Jarrett R F, Brousset P, et al. Epstein–Barr virus-associated Hodgkin's disease: epidemiologic characteristics in international data. Int J Cancer 1997; 70: 375–382
   PubMed Web of Science ®Google Scholar
• Harris N L. The many faces of Hodgkin's disease around the world: what have we learned from its pathology?. Ann Oncol 1998; 9: S45–S56
   PubMedGoogle Scholar
• Kawa K. Epstein–Barr virus-associated diseases in humans. Int J Hematol 2000; 71: 108–117
   PubMed Web of Science ®Google Scholar
• Niedobitek G, Meru N, Delecluse H. Epstein–Barr virus infection and human malignancies. Int J Exp Pathol 2001; 82: 149–170
   PubMed Web of Science ®Google Scholar
• Okano M. Epstein–Barr virus infection and its role in the expanding spectrum of human diseases. Acta Paediatr 1998; 87: 11–18
   PubMed Web of Science ®Google Scholar
• Khan G, Norton A J, Slavin G. Epstein–Barr virus in Hodgkin disease. Relation to age and subtype. Cancer 1993; 71: 3124–3129
   PubMed Web of Science ®Google Scholar
• Kusuda M, Toriyama K, Kamidigo N O, Itakura H. A comparison of epidemiologic, histologic and virologic studies on Hodgkin's disease in Western Kenya and Nagasaki, Japan. Am J Trop Med Hyg 1998; 59: 801–807
   PubMed Web of Science ®Google Scholar
• Leoncini L, Spina D, Nyong’o A, Abinya O, Minacci C, Disanto A, et al. Neoplastic cells of Hodgkin's disease show differences in EBV expression between Kenya and Italy. Int J Cancer 1996; 65: 781–784
   PubMed Web of Science ®Google Scholar
• Liu S M, Chow K C, Chiu C F, Tzeng C H. Expression of Epstein–Barr virus in patients with Hodgkin's disease in Taiwan. Cancer 1998; 83: 367–371
   PubMed Web of Science ®Google Scholar
• Makar R R, Saji T, Junaid T A. Epstein–Barr virus expression in Hodgkin's Lymphoma in Kuwait. Pathol Oncol Res 2003; 9: 159–165
   PubMed Web of Science ®Google Scholar
• Mourad W, Alsohaibani M O, Saddik M, Bazerbashi S. Epstein–Barr virus expression in Hodgkin's disease: correlation with histologic subtypes and T and B lymphocyte distribution. Ann Saudi Med 1998; 18: 296–300
   PubMed Web of Science ®Google Scholar
• Oudejans J J, Jiwa N M, Meijer C J. Epstein–Barr virus in Hodgkin's disease: more than just an innocent bystander. J Pathol 1997; 181: 353–356, Editorial
   PubMed Web of Science ®Google Scholar
• Peh S C, Looi L M, Pallesen G. Epstein–Barr virus (EBV) and Hodgkin's disease in a multi-ethnic population in Malaysia. Histopathology 1997; 30: 227–233
   PubMed Web of Science ®Google Scholar
• Kandil A, Bazarbashi S, Mourad W. The correlation of Epstein–Barr virus expression and lymphocyte subsets with the clinical presentation of nodular sclerosing Hodgkin disease. Cancer 2001; 91: 1957–1963
   PubMed Web of Science ®Google Scholar
• Mughal T I, Robinson W A, Padmos M A. Adult Hodgkin's disease in Saudi Arabia. Eur J Surg Oncol 1985; 11: 41–45
   PubMed Web of Science ®Google Scholar
• Knight J S, Sharma N, Robertson E S. Epstein–Barr virus latent antigen 3C can mediate the degradation of the retinoblastoma protein through an SCF cellular ubiquitin ligase. Proc Natl Acad Sci U S A 2005; 102(20)18562–18566
   PubMed Web of Science ®Google Scholar
• Jarrett R F, Stark G L, White J, Angus B, Alexander F E, Krajewski A S, et al. Impact of tumor Epstein–Barr virus status on presenting features and outcome in age-defined subgroups of patients with classic Hodgkin lymphoma: a population-based study. Blood 2005; 106: 2444–2451
   PubMed Web of Science ®Google Scholar
• Savoldo B, Rooney C M, Di Stasi A, Abken H, Hombach A, Foster A E, et al. Epstein Barr virus specific cytotoxic T lymphocytes expressing the anti-CD30zeta artificial chimeric T-cell receptor for immunotherapy of Hodgkin disease. Blood 2007; 110: 2620–2630
   PubMed Web of Science ®Google Scholar
• Lu X L, Liang Z H, Zhang C E, Lu S J, Weng X F, Wu X W. Induction of the Epstein–Barr virus latent membrane protein 2 antigen-specific cytotoxic T lymphocytes using human leukocyte antigen tetramer-based artificial antigen-presenting cells. Acta Biochim Biophys Sin (Shanghai) 2006; 38: 157–163
   PubMed Web of Science ®Google Scholar
• Park J H, Faller D V. Epstein–Barr virus latent membrane protein-1 induction by histone deacetylase inhibitors mediates induction of intercellular adhesion molecule-1 expression and homotypic aggregation. Virology 2002; 303: 345–363
   PubMed Web of Science ®Google Scholar
• Rowe M, Khanna R, Jacob C A, Argaet V, Kelly A, Powis S, et al. Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein–Barr virus latent membrane protein-1: coordinate upregulation of peptide transporters and HLA class I antigen expression. Eur J Immunol 1995; 25: 1374–1384
   PubMed Web of Science ®Google Scholar
• Murray P G, Billingham L J, Hassan H T, Flavell J R, Nelson P N, Scott K, et al. Effect of Epstein–Barr virus infection on response to chemotherapy and survival in Hodgkin's disease. Blood 1999; 94: 442–447
   PubMed Web of Science ®Google Scholar
• Morente M M, Piris M A, Abraira V, Acevedo A, Aguilera B, Bellas C, et al. Adverse clinical outcome in Hodgkin's disease is associated with loss of retinoblastoma protein expression. High Ki67 proliferation index and absence of Epstein–Barr virus-latent membrane protein 1 expression. Blood 1997; 90: 2429
   PubMed Web of Science ®Google Scholar
• Mei Y P, Zhou J M, Wang Y, Huang H, Deng R, Feng G K, et al. Silencing of LMP1 induces cell cycle arrest and enhances chemosensitivity through inhibition of AKT signaling pathway in EBV-positive nasopharyngeal carcinoma cells. Cell Cycle 2007; 6: 1379–1385
   PubMed Web of Science ®Google Scholar
• Cancer incidence report 1998–2002. UAE: UAE national cancer registry, Department for disease control. Ministry of Health 2002
   Google Scholar
• Almasri N M, Khalidi H S. Epstein–Barr virus expression in Hodgkin's disease in Jordan. Saudi Med J 2004; 25: 770–775
   PubMed Web of Science ®Google Scholar
• Adamson P, Bray F, Costantini A S, Tao M H, Weiderpass E, Roman E. Time trends in the registration of Hodgkin and non-Hodgkin lymphomas in Europe. Eur J Cancer 2007; 43: 391–401
   PubMed Web of Science ®Google Scholar
• Morton L M, Wang S S, Devesa S S, Hartge P, Weisenburger D D, Linet M S. Lymphoma incidence patterns by WHO subtype in the United States, 1992–2001. Blood 2006; 107: 265–276
   PubMed Web of Science ®Google Scholar
• Chai S P, Peh S C, Kim L H, Lim M Y, Gudum H R. The pattern of lymphoma in east Malaysian patients as experienced in the University Hospital, Kuala Lumpur. Malays J Pathol 1999; 21: 45–50
   PubMedGoogle Scholar
• Huh J, Park C, Juhng S, Kim C E, Poppema S, Kim C. A pathologic study of Hodgkin's disease in Korea and its association with Epstein–Barr virus infection. Cancer 1996; 77: 949–955
   PubMed Web of Science ®Google Scholar
• Flavell K J, Murray P G. Hodgkin's disease and the Epstein–Barr virus. J Clin Pathol: Mol Pathol 2000; 53: 262–269
   Web of Science ®Google Scholar
• Mueller N E, Grufferman S. The epidemiology of Hodgkin's disease. Hodgkin's Diseases, P M Mauch, J D Armitage, V Diehl, R T Hoppe, L M Weiss. Lippincott Williams & Wilkins, PhiladelphiaUSA 1999; 61–77
   Google Scholar
• MacMahon B. Epidemiology of Hodgkin's disease. Cancer Res 1966; 26: 1189–1200
   PubMed Web of Science ®Google Scholar
• Azzam S A. High incidence of Hodgkin's disease in children in Lebanon. Cancer Res 1966; 26: 1202–1203
   PubMed Web of Science ®Google Scholar
• Gad-El-Mawla N, El-Deeb B B, Abu-Gabal A, Abdel-Hadi S, Hamza M R, Zikri Z K, et al. Pediatric Hodgkin's disease in Egypt. Cancer 1983; 52: 1129–1131
   PubMed Web of Science ®Google Scholar
• Motawy M S, Omar Y T. Hodgkin's disease in children in Kuwait. Cancer 1986; 57: 2255–2259
   PubMed Web of Science ®Google Scholar
• A1-Idrissi H Y, Ibrahim E M. Hodgkin's disease in adults in Saudi Arabia. Clinical features, prognostic factors and an analysis of therapy. Outcome of combination chemotherapy only for both localized and advanced disease. Int J Cancer 1991; 47: 822–826
   PubMed Web of Science ®Google Scholar
• Chang K L, Albujar P F, Chen Y Y, Johnson R M, Weiss L M. High prevalence of Epstein–Barr virus in the Reed–Sternberg cells of Hodgkin's disease occurring in Peru. Blood 1993; 81: 496–501
   PubMed Web of Science ®Google Scholar
• Enblad G, Sandvej K, Sundström C, Pallesen G, Glimelius B. Epstein–Barr virus distribution in Hodgkin's disease in an unselected Swedish population. Acta Oncologica 1999; 38: 425–429
   PubMed Web of Science ®Google Scholar
• Chapman A L, Rickinson A B, Thomas W A, Jarrett R F, Crocker J, Lee S P. Epstein–Barr virus-specific cytotoxic T lymphocyte responses in the blood and tumor site of Hodgkin's disease patients: implications for a T-cell-based therapy. Cancer Res 2001; 61: 6219–6226
   PubMed Web of Science ®Google Scholar
• Ambinder R F, Browning P J, Lorenzana I, Leventhal B G, Cosenza H, Mann R B, et al. Epstein–Barr virus and childhood Hodgkin's disease in Honduras and the United States. Blood 1993; 81: 462–467
   PubMed Web of Science ®Google Scholar
• Weinreb M, Day P J, Murray P G, Raafat F, Crocker J, Parkes S E, et al. Epstein–Barr virus (EBV) and Hodgkin's disease in children: incidence of EBV latent membrane protein in malignant cells. J Pathol 1992; 168: 365–369
   PubMed Web of Science ®Google Scholar